Novocuff Cervical Control System (CCS)
Preterm Prelabor Rupture of Membranes (PPROM) and Cervical Shortening/Insufficiency
IDE Clinical StudyActive
Key Facts
Indication
Preterm Prelabor Rupture of Membranes (PPROM) and Cervical Shortening/Insufficiency
Phase
IDE Clinical Study
Status
Active
Company
About Novocuff
Novocuff is a clinical-stage medical device company targeting the significant unmet need in preterm birth prevention, specifically for conditions like PPROM and cervical insufficiency. Its core technology is the Novocuff Cervical Control System, a device designed to support and close the cervix to retain amniotic fluid and sustain cervical length, with the goal of extending pregnancy. The company is currently conducting an IDE-approved clinical study (RETAIN) in the U.S. and operates as a pre-revenue, private entity. Its success hinges on clinical validation, regulatory approval, and eventual market adoption of its novel device.
View full company profile